Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1297 clinical trials
Risk of Recurrence of Cervical Artery Dissection During Pregnancy and Puerperium

Many cases of CAD during pregnancy and puerperium have been described, suggesting that pregnancy and puerperium may be potential risk factors for CAD. The purpose of this study is to determine whether pregnancy and puerperium are also recurrence risk factors for CAD.

  • 0 views
  • 19 Feb, 2024
Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib

Patient-level data are abstracted from medical charts of all eligible patients at all participating sites. Information from patients treated with alpelisib will be used to describe the efficacy and safety of alpelisib in PROS patients.

  • 0 views
  • 19 Feb, 2024
Non-specific Back Pain and Spinal Manipulation

To do this, positive responses to treatment, characterized by improvement in pain score, functional capacity, as well as the global perceived change will be evaluated using single and multiple logistic regressions in which biomechanical variables, comfort, expectation will used as potential predictors.

  • 0 views
  • 19 Feb, 2024
Soluble ST2 and Cardiovascular Outcome

Cardiac surgery induces hemodynamic stress on the myocardium, and this process can be associated with significant cardiovascular morbidity and mortality. Soluble suppression of tumorigenicity 2 (sST2) is biomarker of myocardial remodeling and fibrosis; however, little is known regarding their potential association with cardiovascular events.

heart disease
coronary disease
heart surgery
cardiovascular morbidity
  • 0 views
  • 19 Feb, 2024
The Influence of Two Different CO2 Absorbers on Sevoflurane Consumption During Anaesthesia

Therewith, a potentially harmful compound (compound A) is formed that can be nephrotoxic. In the United States, the sevoflurane manufacturer therefore recommends keeping the FGF (FGF) at >2.0 L min-1 if a sodalime CO2 absorbent is used.

sevoflurane
elective surgery
  • 0 views
  • 19 Feb, 2024
Antigen Presentation and Lymphocyte Response in Parkinson's Disease  

The study involves a one time visit involving brief questionnaires and a blood draw of 30 mL (approximately 2 tablespoons) to be collected.

parkinson's disease
bradykinesia
tremor
resting tremor
muscle rigidity
  • 1784 views
  • 19 Feb, 2024
  • 3 locations
Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study

The purpose of this study is to see how useful it is to look for changes and characteristics in your genes (molecules that contain instructions for the development and functioning of the cells) and the genes within the tumour. These characteristics may be useful in choosing treatments for patients for …

  • 0 views
  • 19 Feb, 2024
An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients

This is an observational study designed to learn more about how COVID19 convalescent plasma works in patients with COVID19 compared to those patients who did not receive convalescent plasma treatment. Information about patient recovery will be collected from participants' electronic medical records to evaluate safety, clinical outcomes, and SARS-CoV2 antibody …

SARS
respiratory symptom
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO )

Over the proposed period of 18 months, images and records related to radiation oncology including pretreatment images of at least 500 patients would be annotated and archived in the data bank. The imaging modalities to be covered are X-RAY mammograms, SPECT, CT, CBCT, MR, PET-CT, Ultrasound, digital histopathology, etc.

  • 0 views
  • 19 Feb, 2024
Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure

If predominant sensitization is a risk factor and caused by underrepresented components in bee venom preparations used for VIT, bee venom preparations may be optimized in the future and patients would benefit from a more effective VIT.

  • 0 views
  • 19 Feb, 2024